2015 AAAAI Annual Meeting Disclosure Information Annual Meeting Program Committee Members ...

63 Pages·2015·0.32 MB·English

by  Paul Rushizky

2015 AAAAI Annual Meeting Disclosure Information
Annual Meeting Program Committee Members
Chair

Paul V. Williams, MD FAAAAI
Northwest Asthma and Allergy Center (Director)
Organizational: ACAAI - Committee Member; American Academy of Pediatrics - Immediate Past Chair, Section
on Allergy & Immunology; Chair, Section Forum Management Committee; Washington State Society of Allergy,
Asthma & Immunology - Past President
Conflict Resolution: I have announced this relationship before programs and meetings.

Vice Chair

Mary Beth Fasano, MD FAAAAI
University of IA College Medicine (Professor, Clinical Medicine)
Organizational: ACGME - Member A/I RRC

Members

Leonard B. Bacharier, MD FAAAAI
Washington University (Professor of Pediatrics)
Competing Relationships: NIH/NHLBI/NIAID - Investigator: AsthmaNet, Severe Asthma Research Program,
Inner City Asthma Consortium; DBV Technologies - Consultant; GlaxoSmithKline - Honoraria for lectures;
Merck - Honoraria for lectures, Consultant; AstraZeneca China - Honoraria for lectures; Novartis - Honoraria
for lectures; Teva - Honoraria for lectures, consultant
Organizational: AAAAI - Fellow, Editorial Boards of JACI and JACI: In practice
Conflict Resolution: Will present data from a variety of published peer-reviewed studies.

Bruce G. Bender, PhD FAAAAI
National Jewish Health (Head, Pediatric Behavior Health)
Competing Relationships: GlaxoSmithKline - research funding; Merck - consultant
Organizational: NHLBI - Consultant

Francisco A. Bonilla, MD PhD FAAAAI
Children's Hospital Pediatric Associates (Director, Clinical Immunology Program)
Competing Relationships: Octapharma - Consultant (data safety monitor); UpToDate - Author
Advisory Board: Blood Product Advisory Committee FDA
Honorarium/Gift: Immune Deficiency Foundation Consulting Immunologist Program; Springer
Research Grant: CSL Behring, Inc.
Organizational: Immune Deficiency Foundation - Medical Advisory Committee
Conflict Resolution: In all publications and oral presentations material is evidence-based and does not include
product-specific information except as required by circumstance and based on published data.

David D. Chaplin, MD PhD FAAAAI
University Alabama at Birmingham (Professor)

Asriani M. Chiu, MD FAAAAI
Medical College of Wisconsin (Professor of Pediatrics (Allergy and Immunology) and Medicine; A/I Fellowship
Program Director)
Organizational: ACAAI, ALA - ACAAI's Allergy/Immunology Training Program Directors' Planning Committee,
volunteer consultant specialist for ALA

Timothy J. Craig, DO FAAAAI
PA State College Medicine (Professor of Medicine and Pediatrics)
Competing Relationships: Dyax - speaker, consultant, researcher; Biocryst - Researcher and consultant; CSL
Behring - Consultant, speaker and researcher; Genentech - researcher; Grifols - speaker and researcher; GSK
- researcher; Merck - researcher ; Novartis - researcher; Shire - Researcher and speaker
Organizational: AAAAI - Interest Section Leadership; ACAAI - member, annual meeting planning committee;
AOA, ACOI - member; PAAA - member
Conflict Resolution: Discuss my conflicts before speaking and having them presented on a slide. Avoid
anything but generic terms. Present fair balance. Review presentation with colleagues to ensure balance.

Jeffrey G. Demain, MD FAAAAI
Allergy, Asthma and Immunology Center of AK (Director and Founding Partner)
Organizational: Alaska Family Practice Residency Program - Adjunct Faculty; Alaska Society of Allergy
Asthma & Immunology - Founder and Past-President; Alaska State Medical Association - Delegate; American
Academy of Pediatrics - Fellow; American College of Allergy Asthma and Immunology - Fellow; Anchorage
Medical Society - President; Asthma & Allergy Foundation of America, Alaska Chapter - President-Elect,
Annual Conference Chair; RSLAAIS - Governor Region 6; State of Alaska, Climate Change Advisory Group -
Delegate; University of Alaska, Anchorage - Adjunct Clinical Faculty; University of Washington, Department of
Pediatrics - Clinical Professor

Stephen C. Dreskin, MD PhD FAAAAI
University Colorado Denver (Professor of Medicine and Immunology)
Competing Relationships: National Institutes of Health - Grant Support; Clinical Immunization Safety
Assessment Network supported by the CDC - Consulting; Department of Health and Human Services, Division
of Vaccine Injury Compensation - Consultant; Genentech - Consulting
Organizational: American Academy of Allergy, Asthma, and Immunology - Plenary Committee; American
Board of Allergy and Immunology - Board Member; Aspen Allergy Conference - Board Member

Steve N. Georas, MD
University of Rochester Medical Center (Professor of Medicine; Pulmonary & Critical Care)
Competing Relationships: Parkes Family Foundation - Director, Study of Asthma in Rochester; NIH - Grantee;
Regeneron, Sanofi, Unilever, Genentech, Array Biopharma, Novartis, Abbvie, Celgene, Medimmune - Wife is a
paid consultant
Organizational: AAI - Associate Editor, Journal of Immunology; ATS - Editorial Board, AJRCCM; FDA -
Member of PADAC
Conflict Resolution: I do not accept financial support directly from commercial entities. My wife is an academic
researcher studying atopic dermatitis, and consults with the pharmaceutical industry on drug discovery and
study design. These relationships do not affect my ability to serve the AAAAI. I will announce these
relationships prior to any presentations or meetings to limit the appearance of conflict of interest.

Mitchell H. Grayson, MD FAAAAI
Medical College of Wisconsin (Assoc. Prof. of Pediatrics, Medicine, Microbiology and Molecular Genetics)
Competing Relationships: National Institutes of Health - Grantee; Children's Research Institute of the
Children's Hospital of Wisconsin - Grantee; Polyphor - Grantee
Organizational: AAFA - Board of Directors; AAI - Associate Editor of the Journal of Immunology; ACAAI -
Deputy Editor of the Annals of Allergy, Asthma, and Immunology; Fight Asthma Milwaukee Allies - Director;
ACAAI - Abstract Review Committee; FDA - SGE for PADAC

Angela Haczku, MD PhD FAAAAI
University of California, Davis (Professor of Medicine; Director, Center for Translational Lung Biology)
Competing Relationships: GSK - Principal Investigator; Janssen - Principal Investigator; NIH - Principal
Investigator
Advisory Board: NIH; Veterans Administration; Wiley
Organizational: ATS - committee membership

Daniel J. Jackson, MD
University of Wisconsin School of Medicine and Public Health (Assistant Professor of Pediatric Allergy &
Immunology)
Competing Relationships: NIH - NIAID - Grant; NIH - NHLBI - Grant

David A. Khan, MD FAAAAI
University Texas SW Medical Center (Professor of Medicine)
Competing Relationships: Baxter - Speaker's Bureau; Genentech - Speaker's Bureau; NIH - Co-investigator on
2 studies; Vanberg Family Fund - Primary investigator on studies of mechanisms of rush immunotherapy and
nasal polyposis
Organizational: ACAAI - Co-chair, Allied Health Symoisum Committee; ACAAI - Co-chair, Conjoint Board
Review Committee; JCAAI - Member of Joint Task Force on Practice Parameters

Gurjit K. Khurana Hershey, MD PhD FAAAAI
Cincinnati Children's Hospital Medical Center (Professor Pediatrics)
Competing Relationships: NIH - Grant

Desiree E.S. Larenas Linnemann, MD FAAAAI
Own employer (Head Private Allergy-asthma Clinic)
Competing Relationships: Astra-zeneca - Speaker
Consultant: Pfizer, Novartis, MEDA
Speaker: MSD, Novartis, MEDA, Pfizer, IPI-ASAC
Honorarium/Gift: Novartis, Sanofi, MSD, Pfizer, Senosiain
Research Grant: Novartis, MEDA, MSD, Senosiain, Astrazeneca, Sanofi, TEVA, GSK, Pfizer, UCB, Carnot
Organizational: AAAAI - Chair IRSOC, member AMPC, member PDT; ACAAI - Member immunotherapy
committee, international committee; ARIA - Country coordinator ARIA Mexico; CMICA - Chair immunotherapy
committee; CMICA - Member board of Directors; WAO - member special committee on immunotherapy
Conflict Resolution: I do not accept major financial support, generally it is only speakers fee or limited financial
support to attend a meeting. I have relationships with several entities only to improve the practice of allergy in
general and immunotherapy specifically. I do not accept to give talks to promote directly one brand, but more
to promote how to diagnose and treat different allergic diseases in the right way. As my relationship has been
with several, they balance against one another.

Giselle Mosnaim, MD MS FAAAAI
Rush University Medical Center and The John H. Stroger Jr. Hospital of Cook County (Assistant Professor and
Consulting Attending Physician)
Competing Relationships: National Heart Lung Blood Institute - Research Grant; Patient Centered Research
Outcomes Institute - Research Grant; Teva - Scientific Advisory Board
Stocks: Electrocore, LLC.
Advisory Board: Electrocore, LLC.

Kari C. Nadeau, MD PhD FAAAAI
Stanford University School of Medicine (Associate Professor)

Sally A. Noone, RN MSN
Mt. Sinai Medical Center (Clinical Research Manager)
Consultant: Up To Date
Organizational: FAME - Food Allergy Management and Education - Board Member

Anna H. Nowak-Wegrzyn, MD FAAAAI
Icahn School of Medicine at Mount Sinai (Associate Professor of Pediatrics)
Competing Relationships: NIAID - clinical trial; Nutricia - clinical trial
Advisory Board: Merck
Speaker: Thermofisher Scientific; Nestle
Honorarium/Gift: UpToDate
Organizational: New York Allergy and Asthma Society - Executive Committee Member

Karin A. Pacheco, MD MSPH FAAAAI
National Jewish Medical and Research Center (Associate Professor)
Organizational: AAAAI/ACAAI - Committee to revise Contact Dermatitis practice parameters; ACOEM - REST
Committee to develop diagnostic and treatment guidelines for occupational asthma

Elena E. Perez, MD PhD FAAAAI
University of Miami (Associate Professor)
Competing Relationships: CSL Behring - consultant
Advisory Board: Baxter
Honorarium/Gift: Eastern Allergy Conference 2014; ACAAI Meeting 2013
Organizational: AAAAI - AMPC committee, BCI Secretary; CIS - finance committee member
Conflict Resolution: I limit my talks and discussions to educational/academic content only. I do not function as
a spokesperson for any particular drug or brand.

Anju T. Peters, MD FAAAAI
Northwestern University Medical School (Associate Professor)
Competing Relationships: Baxter - Speaker; Greer - Advisory board
Conflict Resolution: The relationship does not have a bearing on my activities at the AAAAI

Wanda Phipatanakul, MD MS FAAAAI
Boston Children's Hospital (Associate Professor of Pediatrics)

Sarbjit Singh Saini, MD FAAAAI
Johns Hopkins Allergy Asthma Center (Training Program Director)
Competing Relationships: Astra-Zeneca - Research; NIH - Research; Novartis - Consultant/research;
Genentech - Consultant/research
Organizational: Journal of Investigative Dermatology - Associate Editor; UptoDate - Section Editor

Mark F. Sands, MD FAAAAI
Univ. Buffalo, SUNY School of Medicine & Veterans Administration (Associate Professor of Medicine; Staff
Allergist and DEO VHAWNYHCS)

Lynda C. Schneider, MD FAAAAI
Children's Hospital Boston (Director, Allergy Program; Director, Immunology Clinical Research Program)
Competing Relationships: Genentech, Inc - Research Grant; NIH Atopic Dermatitis Research Network -
Investigator; Food Allergy Research and Education - Research Advisory Board; Food Allergy Research and
Education - Research Grant
Advisory Board: Shire
Research Grant: Astellas
Organizational: National Eczema Association - Scientific Advisory Board

Stephen A. Tilles, MD FAAAAI
Northwest Asthma and Allergy Center / ASTHMA Inc. (Partner (NW Asthma and Allergy Center) / Executive
Director (ASTHMA inc.))
Competing Relationships: ASTHMA Inc. Clinical Research Center - I am executive Director of this non-profit
research center
Advisory Board: TEVA; Hycor; Sunovion
Research Grant: Genentech (PI in clinical study); Amphastar (PI in clinical study); Astellas (PI in clinical study);
Medimmune (PI in clinical study); TEVA (PI in clinical study); DBV Technollgies (sub -I in clinical study);
Sanofi-Avenis (PI in clinical study); Bohringer-Ingelheim (PI in clinical study); Astrazeneca (PI in clinical study);
NIH (sub- I in CAMP study); Novartis (PI in clinical study); Amgen (PI in clinical study); Sunovion (PI in clinical
Study); Merck(PI in clinical study); cephalon; Stanford University; Immune Tolerance Network
Organizational: Allergywatch - Editor In Chief; Annals of Allergy, Asthma, and Immunology - Associate Editor;
Joint Task Force for Practice Parameters - Task Force Member; Seattle Food AllergyConsortium -
ExecutiveCommittee Member; University of Washington School of Medicine - Allergy/Immunology Fellowship
Committee
Conflict Resolution: As Executive Director of ASTHMA Inc. I oversee the operations of a non-profit clinical
research center. I am paid a salary that is fixed (except for annual review for cost of living increase) and not
affected by the success of any particular study or studies. The amounts of salary allocated in study budgets
are not paid to me and my salary is not influenced by the study budgets.

Martin Wagenmann, MD FAAAAI
Heinrich-Heine University Duesseldorf (Head of Rhinology, Allergy, and Endoscopic skull base surgery)
Consultant: Bionorica SE, Germany; HAL Allergies GmbH, Germany
Advisory Board: Meda Pharma, Germany; ALK Abello
Speaker: Allergopharma GmbH & Co KG, Germany; HAL Allergies GmbH, Germany; ALK-Abello, Germany;
Bencard Allergie, Germany; Meda Pharma, Germany; ALK Abello
Organizational: German Society of Allergology and Clinical Immunology - Head of the Section
Otorhinolaryngology

Julie Wang, MD FAAAAI
Icahn School of Medicine at Mount Sinai (Associate Professor of Pediatrics)
Competing Relationships: NIH - K23 grant
Consultant: Merck
Advisory Board: JDP Therapeutics, Inc
Honorarium/Gift: UpToDate

Nives Zimmermann, MD FAAAAI
Children's Hospital Medical Center and UC health (Associate Professor)
Competing Relationships: NIH - PI on grant

Faculty

Juan Pablo Abonia, MD
Cincinnati Children's Hospital Medical Center (Associate Professor of Pediatrics)
Competing Relationships: NIH - Consortium of Eosinophilic Gastrointestinal Disease Researchers; NIH -
Epithelial Genes in Inflammation; NIH/NIAID (CoFAR) 2 - Eosinophilic Esophagitis and Food Allergy; PCORI
(Pending) - Comparative Efficacy of Therapies for Eosinophilic Esophagitis
Organizational: Vasculitis Patient-Powered Research Network - Committee Member: V-PPRN Patient
Reported Outcomes & Data Useful in Clinical Trials Work Group

Roshini S. Abraham, PhD FAAAAI
Mayo Clinic (Professor of Medicine & Laboratory Medicine & Pathology)
Organizational: Clinical Immunology Society - Elected Councilor

Seema Sharma Aceves, MD PhD FAAAAI
University of California, San Diego (Associate Professor, Pediatrics, Medicine)
Competing Relationships: NIH - Research Grant; DOD - RESEARCH GRANT
Stocks: Meritage; Patent royalties on oral viscous budesonide
Organizational: American Partnership for Eosinophilic Disorders - Medical advisory board member; The
International Gastrointestinal Researchers - Executive Steering Committee

Steven J. Ackerman, PhD
University of Illinois at Chicago (Professor of Biochemistry and Molecular Genetics, and Medicine)
Competing Relationships: EnteroTrack, LLC - Interim Chief Scientific Officer, Founding Member; FDA; R01
Grant - Principal Investigator; NIH; R21 Grant - Co-Investigator; Receptos, Inc. - Consultant
Organizational: American Partnership for Eosinophilic Diseases (APFED) - Member of the APFED Medical
Advisory Panel; Campaign Urging Research on Eosinophilic Diseases (Cured Foundation) - Member of the
Honorary Board of Directors; Research for Eosinophilic Disorders (R.F.E.D.) - Member of the Advisory Board

Daniel C. Adelman, MD FAAAAI
Alvine Pharmaceuticals, Inc. (Senior Vice President, Development, Chief Medical Officer)
Organizational: Clinical Immunology Society - Secretary/Treasurer; Food Allergy Research Education -
Research Advisory Board Member

Allen D. Adinoff, MD FAAAAI
CO Allergy and Asthma Center (Physician Owner)

Rachana Agrawal, PhD
University of Virginia (Research Scientist)

Akira Akasawa, MD PhD
Tokyo Metropolitan Children's Medical Center (Director of Allergy)
Speaker: NHO Sagamihara Hospital; Environmental restoration and conservation agency; Japanese nursing
association; Minato City; Tokyo Metropolitan foundation for social welfare and public health; Tokorozawa city;
Kawasaki City; Tokyo Medical Association; Setagaya city; Japanese Ministry of Health, Labour and Welfare;
Hokkaido ward ; Tokyo Metropolitan Society of School Health; Musashino city; Ishikawa ward

Cezmi A. Akdis, MD FAAAAI
A) Swiss Institute of Allergy and Asthma Research B) University of Zurich, Switzerland (A) Director (SIAF) B)
Medical Faculty (University of Zurich))
Competing Relationships: Advisory Board Member and Shareholder - Davos Diagnostics (Davos, Switzerland);
Board Member and Shareholder - Alimentary Health Pharma (Davos, Switzerland)
Advisory Board: Circassia (United Kingdom); Allergopharma (Germany); Novartis (Basel, Switzerland) ; Teva
(Amsterdam, the Netherlands); Anergis (Lausanne, Switzerland)
Organizational: CK-CARE Christine Kühne - Center for Allergy Research and Education - Directorium Member
and Speaker; EAACI - Ex-Com Member; Past President; GA2LEN, Global Allergy And Asthma European
Network - Ex-com Member; World Immune Regulation Meetings - Chair, Organizer

Mubeccel Akdis, MD PhD
Swiss Inst. Allergy and Asthma Research (Head of Immunodermatology)
Organizational: FW7 MeDALL - Board member; FW7 Predicta - Board member; WIRM, World Immune
Regulation Meeting, Davos - Organizing committee

Cem Akin, MD PhD FAAAAI
Brigham and Women's Hospital (Associate Professor)
Competing Relationships: Novartis - Consultant
Consultant: Patara Pharma
Organizational: European Competence Network on Mastocytosis - Advisor; The Mastocytosis Society -
Medical Advisory Board
Conflict Resolution: Consultancy agreement is reviewed and approved by my hospital.

Rafeul Alam, MD PhD FAAAAI
National Jewish Health (Professor and Director, Allergy and Immunology)
Competing Relationships: NIH - NIH Grantee ; Elsevier, Inc - Consulting Editor for Immunology & Allergy
Clinics

Neil Alexis, PhD
Center Environmental Med. Asthma/Lung Biology ( Professor of Pediatrics)

Najwa Al-Ghamedi, PharmD
Duquesne University (Pharmacy Research and Academic Fellow)

Gorka Alkorta-Aranburu
University of Chicago (Postdoctoral Scholar)

Zoulfia Allakhverdi, PhD FAAAAI
UHC Sainte-Justine Research Center (Adjunct Investigator (Attachée de recherche))
Christopher D.C. Allen, PhD
University of California, San Francisco (Assistant Professor)
Competing Relationships: NIH NHLBI - Principal Investigator on DP2 grant, 25% salary support; NIH NIAID -
Principal Investigator on R01 grant, 25% salary support

Katrina Jane Allen, MD PhD FAAAAI
Royal Children's Hospital (Paediatric Gastroenterologist/Allergist)
Speaker: Nestle; Nutricia; Aspencare

Beth A. Allison, NP
Coast Allergy/Asthma Center (Nurse Practitioner)

Charles Aloe, MPH
Johns Hopkins University / School of Medicine (Senior Research Data Analyst)

James J. Anderson, MLT
Environmental Allergy Assays (Aerobiologist)

Andrea J. Apter, MD MA MSc FAAAAI
University of Pennsylvania (Professor of Medicine)
Competing Relationships: NHLBI - RC1 (funded-now complete)- PI; NHLBI - R18; PCORI - PI
Organizational: American College of Asthma Allergy & Immunology - Fellow; American College of Physicians -
Fellow; American Thoracic Society - Behavioral Science Assembly program committee; Associate Editor -
Journal of Allergy & Clinical Immunology; Consultant - UPTODATE
Conflict Resolution: The research grant from Bristol-Myers Squibb and AstraZeneca is paid directly to my
institution, and 2.5% of my salary is supported by these grant funds. The research focuses on a diabetes drug,
and is not related to any of their respiratory products.

Andrea Arévalo, MSc.
Fundación Ecuatoriana para la Salud FEPIS-CIEI (Assistant Researcher)

Larry M. Armor, PA MHA
Allergy Partners, PA (CFO)

Jeanette L. Arnold, MSN RN C-FNP
University MS Medical Center (Instructor of Medicine, Family Nurse Practitioner)
Organizational: AAFA - see addition of faculty position with AAFA

Naveen Arora, PhD
CSIR-IGIB (Professor)

Riccardo Asero, MD
Clinica San Carlo (Consultant Specialist in Allergology)

Ulus Atasoy, MD FAAAAI
University of Missouri (Vice Chair of Research, Director of Tom and Anne Smith MD-PhD Program)

Fred (Dan) Atkins, MD FAAAAI
Children's Hospital Colorado (Allergy Section Chief)
Advisory Board: DBV Technologies - MILES DSMB
Honorarium/Gift: Regeneron Pharmaceuticals, Inc.
Organizational: APFED - Medical Advisory Board

John P. Atkinson, MD
Washington University School of Medicine (Professor of Medicine)
Competing Relationships: Kypha Inc - Scientific Advisory Board; Alexion Pharmaceuticals - Research Grant
Advisory Board: Kypha Inc

Claus Bachert, MD PhD
Universitair Ziekenhuis Gent (Professor, Chief of Clinics)
Competing Relationships: ALK - speaker; Bionorica - speaker, board; GSK - speaker; Meda - speaker, board;
MSD - speaker; Novartis - board; Stallergenes - speaker; UCB - speaker; Uriach - speaker, board
Organizational: DGAKI - Vice President; WAO - Executive Board
Conflict Resolution: Spread of bias over many companies, no direct influence in any presentations

Heysung Baek, MD
Kangdong Sacred Heart Hospital (Pediatric Allergy/Immunology Staff)

Sami L. Bahna, MD DrPH FAAAAI
LA State University Health Sciences Center (Prof. Ped./Med., Chf. Al./Imm.)

Sakina S. Bajowala, MD FAAAAI
Kaneland Allergy and Asthma Center (Physician/Owner)
Competing Relationships: Baxter - Speaker
Organizational: FPIES Foundation - Member, Medical Advisory Board
Conflict Resolution: I will include balanced information from FDA-approved immunoglobulin preparations, and
will refrain from using brand-names in any presentation discussing the use of intravenous or subcutaneous
immunoglobulin.

James W. Baker, MD FAAAAI
Baker Allergy Asthma Dermatology (President & CEO)
Competing Relationships: Amgen - principal investigator; Biocryst - principal investigator; CSL Behring -
principal investigator; Dyax - principal investigator; Merck - principal investigator; Mylan - principal investigator;
Optinose - principal investigator; Pearl - principle investigator; Pharming - principal investigator; Sanofi -
principal investigator; Shire - principal investigator; Teva - principal investigator; Glaxo Smith Kline - principal
investigator; Circassia - principal investigator; Circassia - principal investigator; Tenor - principal investigator;
Mylan - principal investigator; Sanofi-Aventis - principal investigator

Susan L. Balcer-Whaley, MPH
Johns Hopkins University School of Medicine (Research Program Manager)
Competing Relationships: Johns Hopkins University - Research Manager employee

Mark Ballow, MD FAAAAI
USF School of Medicine (part time), self-employed (Interim Training Program Director USF)
Competing Relationships: Baxter - speaker; CSL Behring - consultant
Consultant: CSL Behring
Advisory Board: CSL Behring; Baxter; Ketrion
Speaker: ACAAI; Grifols; Baxter; CSL Behring; IDF and USIDNET
Research Grant: CSL Behring
Organizational: Immune Deficiency Foundation - Medical Advisory Committee; Immune Deficiency
Foundation/USIDNET - Le Bien visiting professorship; Kedrion and Green Cross - Medical Board member for
Phase III PSMB Medical Trial
Conflict Resolution: disclosure of relationships

Aleena Banerji, MD
Massachusetts General Hospital (Assistant Professor)
Advisory Board: Shire; Dyax; CSL Behring; Santarus; Biocryst
Research Grant: Shire; Dyax; CSL Behring; Biocryst

Lora Georgieva Bankova, MD
Brigham and Women's Hospital
Taylor A. Banks, MD
Walter Reed National Military Medical Center (Allergy-Immunology Staff Physician)

Priya J. Bansal, MD FAAAAI
Asthma and Allergy Center (Allergist and Immunologist)
Organizational: Illinois Society of Allergy, Asthma, and Immunology - Past President and CME Committee

Alan P. Baptist, MD MPH FAAAAI
University of Michigan, Division of Allergy (Associate Program Director)
Competing Relationships: AHRQ - Research support; NIH-NIA - Research Support; Dyax - Research Support;
Merck - Research Support
Advisory Board: Merck; Boehringer Ingelheim
Conflict Resolution: Introduction slide and announcement of any possible conflicts

Isil B. Barlan, MD
marmara univeristy (Chief of Allergy Immunology)

Charles S. Barnes, PhD FAAAAI
Children's Mercy Hospital (Director of the Allergy/Asthma/Immunology Research Laboratory)
Competing Relationships: Housing and Urban Development Research Grant - Research Grant; US
Department of HUD - Investigator; Rock Acres LLC - Member of Family Corporation engaged in Farming and
Timber production.
Consultant: Clorox Corporation

Kathleen C. Barnes, PhD FAAAAI
Johns Hopkins University (Professor of Medicine)
Competing Relationships: National Institutes of Health - PI/Co-PI/Co-Invest/Collaborator on NIH grants;
Northwestern University - Speaker; UpToDate - Royalties

Fuad M. Baroody, MD FAAAAI
University of Chicago (Professor)
Competing Relationships: Johnson and Johnson - Consultant; Merck Inc. - Speaker Honoraria

Nora A. Barrett, MD FAAAAI
Brigham and Women's Hospital (Assistant Professor in Medicine)

Sachin N. Baxi, MD
Children's Hospital Boston (Instructor of Pediatrics)

Jack M. Becker, MD FAAAAI
MainLine Allergy (Partner)

Donald H. Beezhold, PhD FAAAAI
NIOSH (Division Director)

Paul J. Beggs
Macquarie University (Associate Professor and Acting Head of Department)

Avraham Beigelman, MD MSCI FAAAAI
Washington University School of Medicine (Assistant Professor in Pediatrics)

Steven J. Bensinger, PhD
University of California Los Angeles (Assistant Professor)
Competing Relationships: NIH - grant- salary support
William E. Berger, MD MBA FAAAAI
Allergy and Asthma Associates (Clinical Professor)
Organizational: ACAAI - Past President

Cecilia Berin, PhD
Mount Sinai School of Medicine (Associate Professor)

Cheryl K. Bernstein, RN BSN CCRC
Bernstein Clinical Research Center, LLC (Director of Clinical Research)
Competing Relationships: Cicassia - Research Grant ; Glaxo - Research Grant ; Merck - Research Grant ;
Novartis - Research Grant; Pfizer - Research Grant; Teva - Research Grant

David I. Bernstein, MD FAAAAI
Bernstein Allergy Group and University of Cincinnati (Professor of Medicine and Environmental Health)
Competing Relationships: Array - PI clinical trial; Boeringer Ingelheim - PI or Co-I Clinical Trial; Cephalon - PI
clinical trial, advisory panel; GSK - PI or Co-I Clinical Trial; Merck - PI or Co-I Clinical Trial; Novartis - PI clinical
trial; TEVA - PI or Co-I Clinical Trial; Amgen - PI or Co-I Clinical Trial; Johnson and Johnson - PI or Co-I
Clinical Trial; Merck - Advisory Panel; NIOSH-CDC RO1 - PI ; Novartis - PI or Co-I Clinical Trial; Pfizer - PI or
Co-I Clinical Trial
Organizational: American Board of Allergy and Immunology - Director; Joint Task Force - Joint Task Force
Member - Practice Parameter Committee

Jonathan A. Bernstein, MD FAAAAI
Bernstein Allergy Group and Clinical Research and University of Cincinnati (Professor of Medicine)
Competing Relationships: AstraZeneca - PI and Sub PI; Boehringer-Ingelheim - PI; Dyax - speaker, consultant,
principal investigator; Flint Hills Resources - Director of Immunosurveillance; GSK - Sub-PI; Journal of Asthma
- Editor in Chief; Merck/Schering Plough - Sub-PI; NIAID - U44 collaborative grant; TEVA - speaker, sub-PI;
AMGEN - Sub-PI; Aquinox - PI clinical trial; Basilea/Covance Atopc Dermatitis - Sub-PI; Cephalon - Sub-PI;
CSL Behring - Consultant, speaker and principal Investigator; Forest - PI; Genentech - PI; Greer - Sub-PI;
Medimmune - PI and sub-PI; Novartis - PI in research; Pfizer - Sub-PI; Pharming/Santarus - Principal
Investigator, consultant; Roxane - Sub-PI; Sepracor - Sub-PI; Shire/Viropharma - Consultant, speaker and
principal investigator; MEDA - Principal Investigator and consultant
Organizational: AAAAI - Board of Directors; EORD representative to plenary committee; ACAAI - Fellow of
ACAAI ; AFI - Chairman; Allergy Asthma Proceedings - Editorial Board; Annals of Allergy Asthma and
Immunology - Editorial Board; ART - Northwestern and University of Cincinnati Honor fund chairman;
Cincinnati Allergy Society - Past-President; HAEA organization - Medical Advisory Board; JACI - Editorial
Board; Journal of Angioedema - Editorial Board
Conflict Resolution: I am a PI or Sub-PI for multicenter double blind placebo controlled trials, a physician
initiated investigator and Consultant and speaker for biopharm companies. I have disclosed all of my potential
financial conflicts. I have taken the hippocratic oath to be my patient's advocate at all times. These interests do
not influence my approach to patient care.

Alalia W. Berry, MD
University of Wisconsin Hospitals & Clinics (fellow physician)

J. Andrew Bird, MD FAAAAI
University of Texas Southwestern Medical Center (Assistant Professor)
Speaker: Nutricia
Organizational: FPIES Foundation - Medical Advisory Board Member
Conflict Resolution: I completed the seminar, "Faculty Roles and Responsibilities in Certified Continuing
Medical Education (CME) and FDA Regulated Speaker Programs (RSP) - There is a Difference" on
11/19/2012. In addition, I present only slides I have prepared for requested talks and do not present industry-
provided slides.

Jack J.H. Bleesing, MD PhD
Cincinnati Children's Hospital Medical Center (Physician)